pentobarbital has been researched along with Movement Disorders in 5 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objectives of this study were to describe the type and frequency of postdischarge adverse events related to sedation for elective diagnostic imaging in children and to determine if any patient or drug characteristics were associated with such adverse events." | 1.38 | Postdischarge adverse events related to sedation for diagnostic imaging in children. ( Chen, X; Kaila, R; Kannikeswaran, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, RA | 1 |
| Osterndorff-Kahanek, E | 1 |
| Ponomarev, I | 1 |
| Homanics, GE | 1 |
| Blednov, YA | 1 |
| Kaila, R | 1 |
| Chen, X | 1 |
| Kannikeswaran, N | 1 |
| COULEON, M | 1 |
| COULEON, H | 1 |
| ANNE, L | 1 |
| BLOHORN, R | 1 |
| CLERC, G | 1 |
| Corral, C | 1 |
| Lissavetzky, J | 1 |
| Manzanares, I | 1 |
| Darias, V | 1 |
| Expósito-Orta, MA | 1 |
| Martïn Conde, JA | 1 |
| Sánchez-Mateo, CC | 1 |
| Silva, MT | 1 |
| Calil, HM | 1 |
5 other studies available for pentobarbital and Movement Disorders
| Article | Year |
|---|---|
Testing the silence of mutations: Transcriptomic and behavioral studies of GABA(A) receptor α1 and α2 subunit knock-in mice.
Topics: Animals; Behavior, Animal; Cytoskeletal Proteins; Flurazepam; GABA Modulators; Gene Expression Profi | 2011 |
Postdischarge adverse events related to sedation for diagnostic imaging in children.
Topics: Child; Child, Preschool; Dizziness; Female; Fentanyl; Follow-Up Studies; Humans; Hypnotics and Sedat | 2012 |
[TREATMENT OF PSYCHOMOTOR EXCITATION AND ESPECIALLY MANIC REACTIONS BY COMBINED THIORIDAZINE-NEMBUTAL AND ELECTROSHOCK].
Topics: Bipolar Disorder; Convulsive Therapy; Drug Therapy; Electroconvulsive Therapy; Electroshock; Humans; | 1964 |
Synthesis and preliminary pharmacological evaluation of thiophene analogues of viloxazine as potential antidepressant drugs.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Dose-Response Rela | 1999 |
Screening hallucinogenic drugs: systematic study of three behavioral tests.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Arousal; Behavior, Animal; Chlorpromazine; D | 1975 |